nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Sorafenib—thyroid cancer	0.149	0.252	CbGbCtD
Moclobemide—CYP1A2—Sorafenib—thyroid cancer	0.137	0.232	CbGbCtD
Moclobemide—CYP2C9—Sorafenib—thyroid cancer	0.124	0.209	CbGbCtD
Moclobemide—CYP2D6—Sorafenib—thyroid cancer	0.113	0.191	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—thyroid cancer	0.0686	0.116	CbGbCtD
Moclobemide—Photopsia—Vandetanib—thyroid cancer	0.0321	0.0802	CcSEcCtD
Moclobemide—Bezafibrate—PPARG—thyroid cancer	0.00774	1	CrCbGaD
Moclobemide—Rectal tenesmus—Epirubicin—thyroid cancer	0.00684	0.0171	CcSEcCtD
Moclobemide—Dry skin—Vandetanib—thyroid cancer	0.0068	0.017	CcSEcCtD
Moclobemide—Gastritis—Vandetanib—thyroid cancer	0.00656	0.0164	CcSEcCtD
Moclobemide—Rectal tenesmus—Doxorubicin—thyroid cancer	0.00633	0.0158	CcSEcCtD
Moclobemide—Dysuria—Vandetanib—thyroid cancer	0.00599	0.015	CcSEcCtD
Moclobemide—Stomatitis—Vandetanib—thyroid cancer	0.00557	0.0139	CcSEcCtD
Moclobemide—Conjunctivitis—Vandetanib—thyroid cancer	0.00556	0.0139	CcSEcCtD
Moclobemide—Proctalgia—Epirubicin—thyroid cancer	0.00543	0.0136	CcSEcCtD
Moclobemide—Bradycardia—Vandetanib—thyroid cancer	0.00522	0.013	CcSEcCtD
Moclobemide—Proctalgia—Doxorubicin—thyroid cancer	0.00503	0.0125	CcSEcCtD
Moclobemide—Visual impairment—Vandetanib—thyroid cancer	0.00495	0.0123	CcSEcCtD
Moclobemide—Anorectal discomfort—Epirubicin—thyroid cancer	0.00466	0.0116	CcSEcCtD
Moclobemide—Dry skin—Sorafenib—thyroid cancer	0.00459	0.0114	CcSEcCtD
Moclobemide—Gastritis—Sorafenib—thyroid cancer	0.00443	0.011	CcSEcCtD
Moclobemide—Dysgeusia—Vandetanib—thyroid cancer	0.00437	0.0109	CcSEcCtD
Moclobemide—Anorectal discomfort—Doxorubicin—thyroid cancer	0.00431	0.0108	CcSEcCtD
Moclobemide—Vision blurred—Vandetanib—thyroid cancer	0.00421	0.0105	CcSEcCtD
Moclobemide—Tremor—Vandetanib—thyroid cancer	0.00419	0.0104	CcSEcCtD
Moclobemide—Loss of consciousness—Vandetanib—thyroid cancer	0.00393	0.00979	CcSEcCtD
Moclobemide—Hypertension—Vandetanib—thyroid cancer	0.00386	0.00962	CcSEcCtD
Moclobemide—Chest pain—Vandetanib—thyroid cancer	0.0038	0.00949	CcSEcCtD
Moclobemide—Anxiety—Vandetanib—thyroid cancer	0.00379	0.00945	CcSEcCtD
Moclobemide—Stomatitis—Sorafenib—thyroid cancer	0.00376	0.00938	CcSEcCtD
Moclobemide—Dry mouth—Vandetanib—thyroid cancer	0.00372	0.00928	CcSEcCtD
Moclobemide—Dermatitis atopic—Epirubicin—thyroid cancer	0.00344	0.00859	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00332	0.00829	CcSEcCtD
Moclobemide—Insomnia—Vandetanib—thyroid cancer	0.0033	0.00823	CcSEcCtD
Moclobemide—Paraesthesia—Vandetanib—thyroid cancer	0.00327	0.00817	CcSEcCtD
Moclobemide—Dyspnoea—Vandetanib—thyroid cancer	0.00325	0.00811	CcSEcCtD
Moclobemide—Gingivitis—Epirubicin—thyroid cancer	0.00325	0.0081	CcSEcCtD
Moclobemide—Tinnitus—Sorafenib—thyroid cancer	0.00323	0.00805	CcSEcCtD
Moclobemide—Flushing—Sorafenib—thyroid cancer	0.00321	0.00801	CcSEcCtD
Moclobemide—Dyspepsia—Vandetanib—thyroid cancer	0.00321	0.008	CcSEcCtD
Moclobemide—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00318	0.00794	CcSEcCtD
Moclobemide—Decreased appetite—Vandetanib—thyroid cancer	0.00317	0.00791	CcSEcCtD
Moclobemide—Fatigue—Vandetanib—thyroid cancer	0.00314	0.00784	CcSEcCtD
Moclobemide—Constipation—Vandetanib—thyroid cancer	0.00312	0.00778	CcSEcCtD
Moclobemide—Gingivitis—Doxorubicin—thyroid cancer	0.003	0.00749	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00298	0.00744	CcSEcCtD
Moclobemide—Dysgeusia—Sorafenib—thyroid cancer	0.00295	0.00736	CcSEcCtD
Moclobemide—Abdominal pain—Vandetanib—thyroid cancer	0.00288	0.00719	CcSEcCtD
Moclobemide—Syncope—Sorafenib—thyroid cancer	0.0027	0.00674	CcSEcCtD
Moclobemide—Dysarthria—Epirubicin—thyroid cancer	0.00269	0.00672	CcSEcCtD
Moclobemide—Loss of consciousness—Sorafenib—thyroid cancer	0.00265	0.00661	CcSEcCtD
Moclobemide—Asthenia—Vandetanib—thyroid cancer	0.00262	0.00652	CcSEcCtD
Moclobemide—Hypertension—Sorafenib—thyroid cancer	0.0026	0.00649	CcSEcCtD
Moclobemide—Pruritus—Vandetanib—thyroid cancer	0.00258	0.00643	CcSEcCtD
Moclobemide—Myalgia—Sorafenib—thyroid cancer	0.00257	0.0064	CcSEcCtD
Moclobemide—Dry mouth—Sorafenib—thyroid cancer	0.00251	0.00626	CcSEcCtD
Moclobemide—Diarrhoea—Vandetanib—thyroid cancer	0.00249	0.00622	CcSEcCtD
Moclobemide—Dysarthria—Doxorubicin—thyroid cancer	0.00249	0.00622	CcSEcCtD
Moclobemide—Shock—Sorafenib—thyroid cancer	0.00242	0.00604	CcSEcCtD
Moclobemide—Dizziness—Vandetanib—thyroid cancer	0.00241	0.00601	CcSEcCtD
Moclobemide—Vomiting—Vandetanib—thyroid cancer	0.00232	0.00578	CcSEcCtD
Moclobemide—Rash—Vandetanib—thyroid cancer	0.0023	0.00573	CcSEcCtD
Moclobemide—Dermatitis—Vandetanib—thyroid cancer	0.0023	0.00573	CcSEcCtD
Moclobemide—Headache—Vandetanib—thyroid cancer	0.00228	0.0057	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00224	0.00559	CcSEcCtD
Moclobemide—Dyspnoea—Sorafenib—thyroid cancer	0.00219	0.00547	CcSEcCtD
Moclobemide—Nausea—Vandetanib—thyroid cancer	0.00217	0.0054	CcSEcCtD
Moclobemide—Dyspepsia—Sorafenib—thyroid cancer	0.00216	0.0054	CcSEcCtD
Moclobemide—Decreased appetite—Sorafenib—thyroid cancer	0.00214	0.00533	CcSEcCtD
Moclobemide—Fatigue—Sorafenib—thyroid cancer	0.00212	0.00529	CcSEcCtD
Moclobemide—Constipation—Sorafenib—thyroid cancer	0.0021	0.00525	CcSEcCtD
Moclobemide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00201	0.00502	CcSEcCtD
Moclobemide—Hot flush—Epirubicin—thyroid cancer	0.00198	0.00493	CcSEcCtD
Moclobemide—Menopausal symptoms—Epirubicin—thyroid cancer	0.00196	0.00489	CcSEcCtD
Moclobemide—Urticaria—Sorafenib—thyroid cancer	0.00195	0.00487	CcSEcCtD
Moclobemide—Abdominal pain—Sorafenib—thyroid cancer	0.00194	0.00485	CcSEcCtD
Moclobemide—Osteoarthritis—Epirubicin—thyroid cancer	0.00185	0.00461	CcSEcCtD
Moclobemide—Hot flush—Doxorubicin—thyroid cancer	0.00183	0.00456	CcSEcCtD
Moclobemide—Migraine—Epirubicin—thyroid cancer	0.00182	0.00454	CcSEcCtD
Moclobemide—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00181	0.00452	CcSEcCtD
Moclobemide—Asthenia—Sorafenib—thyroid cancer	0.00176	0.0044	CcSEcCtD
Moclobemide—Pruritus—Sorafenib—thyroid cancer	0.00174	0.00434	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—thyroid cancer	0.00171	0.00427	CcSEcCtD
Moclobemide—Dry skin—Epirubicin—thyroid cancer	0.00169	0.00423	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—thyroid cancer	0.00168	0.0042	CcSEcCtD
Moclobemide—Diarrhoea—Sorafenib—thyroid cancer	0.00168	0.0042	CcSEcCtD
Moclobemide—Gastritis—Epirubicin—thyroid cancer	0.00164	0.00408	CcSEcCtD
Moclobemide—Dizziness—Sorafenib—thyroid cancer	0.00163	0.00406	CcSEcCtD
Moclobemide—Abdominal distension—Epirubicin—thyroid cancer	0.00161	0.00401	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—thyroid cancer	0.00157	0.00391	CcSEcCtD
Moclobemide—Vomiting—Sorafenib—thyroid cancer	0.00156	0.0039	CcSEcCtD
Moclobemide—Angina pectoris—Epirubicin—thyroid cancer	0.00156	0.00388	CcSEcCtD
Moclobemide—Rash—Sorafenib—thyroid cancer	0.00155	0.00387	CcSEcCtD
Moclobemide—Dermatitis—Sorafenib—thyroid cancer	0.00155	0.00386	CcSEcCtD
Moclobemide—Headache—Sorafenib—thyroid cancer	0.00154	0.00384	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—thyroid cancer	0.00151	0.00378	CcSEcCtD
Moclobemide—Dysuria—Epirubicin—thyroid cancer	0.00149	0.00373	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—thyroid cancer	0.00149	0.00371	CcSEcCtD
Moclobemide—Nausea—Sorafenib—thyroid cancer	0.00146	0.00364	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—thyroid cancer	0.00144	0.00359	CcSEcCtD
Moclobemide—Drowsiness—Epirubicin—thyroid cancer	0.00143	0.00355	CcSEcCtD
Moclobemide—Stomatitis—Epirubicin—thyroid cancer	0.00139	0.00346	CcSEcCtD
Moclobemide—Conjunctivitis—Epirubicin—thyroid cancer	0.00139	0.00346	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—thyroid cancer	0.00138	0.00345	CcSEcCtD
Moclobemide—Sweating—Epirubicin—thyroid cancer	0.00137	0.00341	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—thyroid cancer	0.00132	0.00329	CcSEcCtD
Moclobemide—Bradycardia—Epirubicin—thyroid cancer	0.0013	0.00325	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—thyroid cancer	0.00129	0.00321	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—thyroid cancer	0.00128	0.0032	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—thyroid cancer	0.00126	0.00315	CcSEcCtD
Moclobemide—Visual impairment—Epirubicin—thyroid cancer	0.00123	0.00308	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—thyroid cancer	0.0012	0.00301	CcSEcCtD
Moclobemide—Tinnitus—Epirubicin—thyroid cancer	0.00119	0.00298	CcSEcCtD
Moclobemide—Flushing—Epirubicin—thyroid cancer	0.00119	0.00296	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—thyroid cancer	0.00114	0.00285	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—thyroid cancer	0.0011	0.00275	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—thyroid cancer	0.0011	0.00274	CcSEcCtD
Moclobemide—Flatulence—Epirubicin—thyroid cancer	0.0011	0.00274	CcSEcCtD
Moclobemide—Tension—Epirubicin—thyroid cancer	0.00109	0.00273	CcSEcCtD
Moclobemide—Dysgeusia—Epirubicin—thyroid cancer	0.00109	0.00272	CcSEcCtD
Moclobemide—Nervousness—Epirubicin—thyroid cancer	0.00108	0.0027	CcSEcCtD
Moclobemide—Vision blurred—Epirubicin—thyroid cancer	0.00105	0.00262	CcSEcCtD
Moclobemide—Ill-defined disorder—Epirubicin—thyroid cancer	0.00103	0.00258	CcSEcCtD
Moclobemide—Agitation—Epirubicin—thyroid cancer	0.00102	0.00255	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—thyroid cancer	0.00102	0.00253	CcSEcCtD
Moclobemide—Tension—Doxorubicin—thyroid cancer	0.00101	0.00252	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—thyroid cancer	0.00101	0.00252	CcSEcCtD
Moclobemide—Malaise—Epirubicin—thyroid cancer	0.001	0.00251	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—thyroid cancer	0.001	0.0025	CcSEcCtD
Moclobemide—Syncope—Epirubicin—thyroid cancer	0.000999	0.00249	CcSEcCtD
Moclobemide—Palpitations—Epirubicin—thyroid cancer	0.000984	0.00245	CcSEcCtD
Moclobemide—Loss of consciousness—Epirubicin—thyroid cancer	0.000979	0.00244	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—thyroid cancer	0.000971	0.00242	CcSEcCtD
Moclobemide—Hypertension—Epirubicin—thyroid cancer	0.000961	0.0024	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000956	0.00238	CcSEcCtD
Moclobemide—Chest pain—Epirubicin—thyroid cancer	0.000948	0.00236	CcSEcCtD
Moclobemide—Myalgia—Epirubicin—thyroid cancer	0.000948	0.00236	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—thyroid cancer	0.000947	0.00236	CcSEcCtD
Moclobemide—Anxiety—Epirubicin—thyroid cancer	0.000945	0.00236	CcSEcCtD
Moclobemide—Discomfort—Epirubicin—thyroid cancer	0.000937	0.00234	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—thyroid cancer	0.000929	0.00232	CcSEcCtD
Moclobemide—Dry mouth—Epirubicin—thyroid cancer	0.000927	0.00231	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—thyroid cancer	0.000924	0.0023	CcSEcCtD
Moclobemide—Confusional state—Epirubicin—thyroid cancer	0.000916	0.00229	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—thyroid cancer	0.000911	0.00227	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—thyroid cancer	0.000906	0.00226	CcSEcCtD
Moclobemide—Shock—Epirubicin—thyroid cancer	0.000894	0.00223	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—thyroid cancer	0.00089	0.00222	CcSEcCtD
Moclobemide—Tachycardia—Epirubicin—thyroid cancer	0.000887	0.00221	CcSEcCtD
Moclobemide—Hyperhidrosis—Epirubicin—thyroid cancer	0.000879	0.00219	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—thyroid cancer	0.000877	0.00219	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—thyroid cancer	0.000877	0.00219	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—thyroid cancer	0.000874	0.00218	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—thyroid cancer	0.000867	0.00216	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—thyroid cancer	0.000858	0.00214	CcSEcCtD
Moclobemide—Hypotension—Epirubicin—thyroid cancer	0.000849	0.00212	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—thyroid cancer	0.000848	0.00212	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000828	0.00207	CcSEcCtD
Moclobemide—Shock—Doxorubicin—thyroid cancer	0.000827	0.00206	CcSEcCtD
Moclobemide—Insomnia—Epirubicin—thyroid cancer	0.000822	0.00205	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—thyroid cancer	0.000821	0.00205	CcSEcCtD
Moclobemide—Paraesthesia—Epirubicin—thyroid cancer	0.000816	0.00204	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000813	0.00203	CcSEcCtD
Moclobemide—Dyspnoea—Epirubicin—thyroid cancer	0.00081	0.00202	CcSEcCtD
Moclobemide—Somnolence—Epirubicin—thyroid cancer	0.000808	0.00202	CcSEcCtD
Moclobemide—Dyspepsia—Epirubicin—thyroid cancer	0.0008	0.002	CcSEcCtD
Moclobemide—Decreased appetite—Epirubicin—thyroid cancer	0.00079	0.00197	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—thyroid cancer	0.000786	0.00196	CcSEcCtD
Moclobemide—Fatigue—Epirubicin—thyroid cancer	0.000784	0.00195	CcSEcCtD
Moclobemide—Constipation—Epirubicin—thyroid cancer	0.000777	0.00194	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000766	0.00191	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—thyroid cancer	0.000761	0.0019	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—thyroid cancer	0.000755	0.00188	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—thyroid cancer	0.00075	0.00187	CcSEcCtD
Moclobemide—Feeling abnormal—Epirubicin—thyroid cancer	0.000749	0.00187	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—thyroid cancer	0.000748	0.00186	CcSEcCtD
Moclobemide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000743	0.00185	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—thyroid cancer	0.00074	0.00185	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—thyroid cancer	0.000731	0.00182	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—thyroid cancer	0.000725	0.00181	CcSEcCtD
Moclobemide—Urticaria—Epirubicin—thyroid cancer	0.000722	0.0018	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—thyroid cancer	0.000719	0.00179	CcSEcCtD
Moclobemide—Abdominal pain—Epirubicin—thyroid cancer	0.000718	0.00179	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—thyroid cancer	0.000693	0.00173	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000688	0.00172	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—thyroid cancer	0.000668	0.00167	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—thyroid cancer	0.000665	0.00166	CcSEcCtD
Moclobemide—Asthenia—Epirubicin—thyroid cancer	0.000652	0.00163	CcSEcCtD
Moclobemide—Pruritus—Epirubicin—thyroid cancer	0.000643	0.0016	CcSEcCtD
Moclobemide—Diarrhoea—Epirubicin—thyroid cancer	0.000622	0.00155	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—thyroid cancer	0.000603	0.00151	CcSEcCtD
Moclobemide—Dizziness—Epirubicin—thyroid cancer	0.000601	0.0015	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—thyroid cancer	0.000595	0.00148	CcSEcCtD
Moclobemide—Vomiting—Epirubicin—thyroid cancer	0.000578	0.00144	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—thyroid cancer	0.000575	0.00144	CcSEcCtD
Moclobemide—Rash—Epirubicin—thyroid cancer	0.000573	0.00143	CcSEcCtD
Moclobemide—Dermatitis—Epirubicin—thyroid cancer	0.000573	0.00143	CcSEcCtD
Moclobemide—Headache—Epirubicin—thyroid cancer	0.000569	0.00142	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—thyroid cancer	0.000556	0.00139	CcSEcCtD
Moclobemide—Nausea—Epirubicin—thyroid cancer	0.00054	0.00135	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—thyroid cancer	0.000535	0.00133	CcSEcCtD
Moclobemide—Rash—Doxorubicin—thyroid cancer	0.00053	0.00132	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—thyroid cancer	0.00053	0.00132	CcSEcCtD
Moclobemide—Headache—Doxorubicin—thyroid cancer	0.000527	0.00131	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—thyroid cancer	0.0005	0.00125	CcSEcCtD
